Sofwave Synchronous Ultrasound Parallel Beam (SUPERB)
Taking Non-Invasive Aesthetic Treatment to the Next Level

Aesthetic medicine has been incredibly successful in advancing cosmetic and beauty treatments through leading-edge technologies to treat aging signs, like fine lines, wrinkles, or crow’s feet. The domain is now advancing beyond the familiar Botox to bring forth a new era of non-invasive aesthetic treatments with a hard no to needles.

Medical equipment manufacturing company Sofwave’s proprietary next-generation ultrasound technology, Synchronous Ultrasound Parallel Beam (SUPERB), is achieving this remarkable feat in the evolution of non-invasive skin rejuvenation treatments.

Sofwave is an FDA-cleared, non-invasive aesthetic treatment technology that revitalizes the skin by regenerating and increasing collagen and elastin fibers. It improves facial appearance by reducing fine lines and wrinkles and provides a lifting effect to the eyebrows, neck, and submental region without requiring needles, incisions, or anesthesia.

Sofwave’s unique applicator has seven individual ultrasound transducers that allow direct contact with the skin surface. It provides an array of high-intensity, high-frequency, and parallel ultrasound beams, which generate the right temperature at the right depth for wrinkle treatment (at a depth of 1.5 mm in the mid-dermis). SUPERB delivers a broader tissue impact, eventually leading to more collagen remodeling.

It also has an integrated cooling mechanism, Sofcool, which protects the epidermis and the layers underneath the dermis.

“No matter the skin type or color, Sofwave delivers the best results while keeping the comfort of aesthetic providers and patients in mind,” states Louis Scafuri, CEO of Sofwave.

Convenience is the name of the game for Sofwave. Patients can receive a full-face treatment within 45 minutes. The treatment seamlessly fits into an active lifestyle, and patients can return to their daily activities swiftly after. Adding to it is the treatment’s efficacy; results can be seen within two weeks of the treatment. Most patients were categorized as “improved” to “very much improved” after just one Sofwave treatment session during the clinical study.

At the core of such a futuristic solution is a group of industry experts with decades of expertise in pioneering and introducing some highly acclaimed state-of-the-art technologies in the aesthetic treatment space, including microneedling and ablative CO2 lasers. The management team’s vast experience, coupled with their collaboration with an extensive worldwide network of key thought leaders, makes Sofwave one of the most sought-after technologies in the aesthetic treatment market.

Sofwave is on the fast track to growth in North America, the Philippines, Korea, Japan, and Taiwan, along with countries in Europe, the Middle East, and Africa. Sofwave is focusing on extending its technology by adding applications for acne treatment, scar reduction, cellulite removal, and body, which are currently undergoing FDA-controlled clinical studies. Sofwave intends to remain at the helm of the non-invasive skin treatment domain with these developments.